These San Francisco startups have emerged as stars in the fight against COVID this year due to their focus on biotech.
The massive round is the company’s first since it closed on its Series C in April of last year. Since then, its valuation has more than doubled.
Workato will use the new funding to invest in product research and technology development. The company’s platform works to centralize apps, data, APIs, integrations and process automation for business and IT users.
Vir Biotechnology ranked as North America’s no. 1 fastest-growing company for another consecutive year.
The platform works to help businesses reinforce trust-based partnerships along their supply chains.
Here’s what you may have missed in the world of SF tech.
Here’s what you may have missed in the world of San Francisco tech.
The solution aims to paint a comprehensive picture of a student based on who they are both in and outside of the classroom.
The company plans to use its new funds to hire new talent, add product integrations and reach more customers.
We're always looking for news.
